go to medicines.ie homepage
Font Size
Search for:  
select
  Advanced Search

Amgen Ltd
240 Cambridge Science Park, Milton Road, Cambridge, Cambridgeshire, CB4 0WD, UK
Telephone: +44 (0)1223 420 305
Fax: +44 (0)1223 426 314
Medical Information Direct Line: +44 (0)1223 436 441/Freephone: 1800 535160
Medical Information e-mail: gbinfoline@amgen.com
Customer Care direct line: +44 (0)1223 436441/Freephone: 1800 535160
Patient Information Leaflet last updated on medicines.ie: 14/12/2011
PIL Aranesp SureClick

When a pharmaceutical company changes an SPC or PIL, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 14/12/2011 and displayed until Current
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
  • Change to improve clarity and readability
Updated on 29/03/2011 and displayed until 14/12/2011
Reasons for adding or updating:
  • Change to, or new use for medicine
  • Change to warnings or special precautions for use
  • Change of contraindications
  • Change to storage instructions
  • Change to drug interactions
  • Change to information about driving or using machinery
  • Change to further information section
  • Change to date of revision
Updated on 07/02/2011 and displayed until 29/03/2011
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 09/09/2010 and displayed until 07/02/2011
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to further information section
  • Change to date of revision
Updated on 13/05/2010 and displayed until 09/09/2010
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 22/12/2009 and displayed until 13/05/2010
Reasons for adding or updating:
  • Change to instructions about overdose
  • Change to side-effects
  • Change to date of revision
Updated on 04/12/2008 and displayed until 22/12/2009
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 30/10/2008 and displayed until 04/12/2008
Reasons for adding or updating:
  • Change to side-effects
Updated on 19/03/2008 and displayed until 30/10/2008
Reasons for adding or updating:
  • Improved electronic presentation
  • Change to side-effects
  • Change to dosage and administration
Updated on 06/11/2007 and displayed until 19/03/2008
Reasons for adding or updating:
  • Changes to therapeutic indications
Updated on 26/07/2007 and displayed until 06/11/2007
Reasons for adding or updating:
  • Introduction of new strength
Updated on 17/01/2007 and displayed until 26/07/2007
Reasons for adding or updating:
  • Change to date of revision
  • Change to dosage and administration
Updated on 28/08/2006 and displayed until 17/01/2007
Reasons for adding or updating:
  • Change to date of revision
Updated on 14/06/2006 and displayed until 28/08/2006
Reasons for adding or updating:
  • Improved electronic presentation
  • Change to date of revision
  • Change to dosage and administration
Updated on 22/03/2006 and displayed until 14/06/2006
Reasons for adding or updating:
  • Change to date of revision
  • Change to dosage and administration
Updated on 21/11/2005 and displayed until 22/03/2006
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 27/07/2005 and displayed until 21/11/2005
Reasons for adding or updating:
  • Change to, or new use for medicine
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 13/06/2005 and displayed until 27/07/2005
Reasons for adding or updating:
  • New PIL for new product

Document Links

 
  View all medicines
from this company
View Document
Bookmark and Share

Active Ingredients

 
  Darbepoetin alfa